A2 Biotherapeutics, Inc., a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, announced the appointment of James Robinson as its Chief Executive Officer and a member of its Board of Directors, effective April 1st, 2024. Robinson succeeds Scott Foraker, A2...
VRG50635 is one of the first clinical-stage drugs discovered and developed entirely using an AI-powered platform
Verge Genomics, a leading clinical-stage biotechnology company, and Ferrer, a global pharmaceutical B Corp company with a growing focus on rare neurological disorders, have announced a strategic collaboration for the co-development of VRG50635, Verge's...
AI combined with expert guidance to better support medical affairs by delivering insights rooted in real data for more impactful communications
Lumanity, a global life sciences strategic services partner, and Sorcero, a leading provider of advanced AI solutions purpose-built for life sciences, announced a partnership to deliver AI-powered medical strategy...
Profluent, an AI-first protein design company, announced the close of additional funding to bring the total raised to $44M. The $35M financing was led by Spark Capital, with participation from existing investors Insight Partners and Air Street Capital along with a syndicate of angel investors from OpenAI, Salesforce, Octant Bio,...
Acquisition of MotionHall reinforces strategy to lead market-specific solutions, including workflows and expert services fuelled by industry vertical AI
Clarivate Plc a leading global provider of transformative intelligence, has announced an agreement to acquire the substantial majority of assets of MotionHall, a Silicon Valley technology start-up company serving the life sciences...
Ibex Medical Analytics (Ibex), the leader in AI-powered cancer diagnostics, announced excellent results across multiple clinical studies conducted with the University of Pittsburgh Medical Center (UPMC), Brigham and Women's Hospital, Champalimaud Foundation and Ohio State University (OSU). These studies, highlighting the value of Ibex's AI-powered cancer diagnostics solutions in both diagnostic quality...
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™.
IPA, an artificial intelligence-driven biotherapeutic research and technology company, announced that it has acquired the LSA® instrument platform from Carterra®, a leading provider of high-throughput large and small molecule screening and characterization solutions. This instrument...
RCH Solutions, Inc, a leading provider of Bio-IT expertise exclusively for the Life Sciences, announces the introduction of new, cutting-edge AI services to revolutionize drug discovery and development. One of the first to embrace this industry paradigm shift toward AI and machine learning, the new AI services from RCH...
BenevolentAI, a leader in applying advanced AI to accelerate biopharma drug discovery, announces that the current Chief Technology Officer (CTO), Dr. Daniel Neil, is leaving the Company at the beginning of April after 7 years at BenevolentAI to relocate to be nearer his family. The Company is pleased to...
Ambiq, a technology leader in ultra-low power semiconductors to enable local AI on devices, partners with Smartaly, a designer of electronics to develop an energy-efficient and intelligent handheld electrocardiogram (ECG) monitor, tested in hospitals for widespread use.
Smartaly's handheld ECG relies on the Apollo3 SoC with built-in AI to monitor...
